SE8403912D0 - Lekemedelssats eller -komposition - Google Patents

Lekemedelssats eller -komposition

Info

Publication number
SE8403912D0
SE8403912D0 SE8403912A SE8403912A SE8403912D0 SE 8403912 D0 SE8403912 D0 SE 8403912D0 SE 8403912 A SE8403912 A SE 8403912A SE 8403912 A SE8403912 A SE 8403912A SE 8403912 D0 SE8403912 D0 SE 8403912D0
Authority
SE
Sweden
Prior art keywords
physiologically acceptable
composition
pharmaceutical kit
drug
carrier
Prior art date
Application number
SE8403912A
Other languages
English (en)
Inventor
K-E Arfors
B Gerdin
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE8403912A priority Critical patent/SE8403912D0/sv
Publication of SE8403912D0 publication Critical patent/SE8403912D0/sv
Priority to CA000487656A priority patent/CA1246449A/en
Priority to PCT/SE1985/000296 priority patent/WO1986000812A1/en
Priority to JP50341185A priority patent/JPS61502821A/ja
Priority to EP19850903893 priority patent/EP0188595A1/en
Priority to AU46713/85A priority patent/AU4671385A/en

Links

SE8403912A 1984-07-30 1984-07-30 Lekemedelssats eller -komposition SE8403912D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE8403912A SE8403912D0 (sv) 1984-07-30 1984-07-30 Lekemedelssats eller -komposition
CA000487656A CA1246449A (en) 1984-07-30 1985-07-29 Drug kit or drug composition for ischaemic damage
PCT/SE1985/000296 WO1986000812A1 (en) 1984-07-30 1985-07-30 A drug kit or drug composition for use in preventing and treating ischaemic cell damage and preparation thereof
JP50341185A JPS61502821A (ja) 1984-07-30 1985-07-30 薬物キットまたは薬物組成物
EP19850903893 EP0188595A1 (en) 1984-07-30 1985-07-30 A drug kit or drug composition for use in preventing and treating ischaemic cell damage and preparation thereof
AU46713/85A AU4671385A (en) 1984-07-30 1985-07-30 A drug kit or drug composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8403912A SE8403912D0 (sv) 1984-07-30 1984-07-30 Lekemedelssats eller -komposition

Publications (1)

Publication Number Publication Date
SE8403912D0 true SE8403912D0 (sv) 1984-07-30

Family

ID=20356627

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403912A SE8403912D0 (sv) 1984-07-30 1984-07-30 Lekemedelssats eller -komposition

Country Status (6)

Country Link
EP (1) EP0188595A1 (sv)
JP (1) JPS61502821A (sv)
AU (1) AU4671385A (sv)
CA (1) CA1246449A (sv)
SE (1) SE8403912D0 (sv)
WO (1) WO1986000812A1 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939146A (en) * 1987-01-29 1990-07-03 Kramer Richard S Method for alleviating ischemic-reperfusion injury
ES2007994A6 (es) * 1988-08-16 1989-07-01 Grino Boira Jose Maria Medio liquido para perfusion y preservacion de organos.
CH683485A5 (fr) * 1990-11-20 1994-03-31 Pasteur Merieux Serums Vacc Solutions de perfusion, de conservation et de reperfusion d'organes.
AU5365494A (en) * 1992-10-22 1994-05-09 Peter G. Thomas New method of protecting central nervous system against damage resulting from cerebrovascular or neuronal compromise
US6265385B1 (en) 1996-01-11 2001-07-24 Topo Target Aps Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy
DE69724228T2 (de) * 1996-01-11 2004-06-09 Topotarget Aps Kombinationstherapie von topoisomerase ii toxinen und bis-dioxypiperazinderivaten
US5834178C1 (en) * 1997-07-09 2002-04-23 Univ Wayne State Flush-storage solution for donor organs
US6977140B1 (en) 1998-09-29 2005-12-20 Organ Recovery Systems, Inc. Method for maintaining and/or restoring viability of organs
AU6274899A (en) * 1998-09-29 2000-04-17 Organ Recovery Systems, Inc. Apparatus and method for maintaining and/or restoring viability of organs
US6485959B1 (en) * 1998-10-07 2002-11-26 Cedars Sinai Medical Center Cell preconditioning and cryopresevation medium
JP2001026536A (ja) * 1999-05-10 2001-01-30 Nikken Kasei Kk ラジカルスカベンジャー
US6492103B1 (en) * 2000-01-31 2002-12-10 Organ Recovery Systems, Inc. System for organ and tissue preservation and hypothermic blood substitution
WO2007105179A1 (en) * 2006-03-15 2007-09-20 Universitat Bern Cardioplegic solution
ES2533475T3 (es) * 2008-08-22 2015-04-10 Universität Bern Preparado cardiopléjico

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2532183C3 (de) * 1975-07-18 1982-03-04 Behringwerke Ag, 3550 Marburg Polyionische isotonische Salzlösung zur Konservierung von Erythrozyten oder zur Perfusion und zur Konservierung von zur Transplantion bestimmter Organen
CH639270A5 (de) * 1978-12-14 1983-11-15 Koehler Franz Dr Chemie Kg Protektive loesung fuer herz und niere.
FR2490963B1 (fr) * 1980-09-30 1986-04-18 Science Union & Cie Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine
ATE11736T1 (de) * 1980-12-23 1985-02-15 Dr. Franz Koehler Chemie Gmbh Protektive loesung fuer herz und niere und verfahren zu deren herstellung.
SE8200252L (sv) * 1982-01-18 1983-07-19 Pharmacia Ab Farmaceutisk komposition
GB8308126D0 (en) * 1983-03-24 1983-05-05 Bloch M Pharmaceutical compositions

Also Published As

Publication number Publication date
JPS61502821A (ja) 1986-12-04
CA1246449A (en) 1988-12-13
WO1986000812A1 (en) 1986-02-13
AU4671385A (en) 1986-02-25
EP0188595A1 (en) 1986-07-30

Similar Documents

Publication Publication Date Title
SE8403912D0 (sv) Lekemedelssats eller -komposition
ATE59297T1 (de) Topische antimikrobielle pharmazeutische zusammensetzung enthaltend eine silberverbindung und ein azol.
ATE252081T1 (de) Neue hiv-protease-inhibitoren
NO20014662D0 (no) Fremgangsmåter og preparater for behandling av faste tumorer
ATE175412T1 (de) Hiv-protease-inhibitoren
KR870005637A (ko) 약물 데포
ATE311227T1 (de) Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
FI953748A (sv) Föreningar med både kraftig kalciumantagonistisk och antioxidantaktivitet samt användning av dessa som cellskyddande ämnen
UY26635A1 (es) Métodos sinérgicos y composiciones para el tratamiento del cáncer
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DK0923570T3 (da) Pyridylalken- og pyridylalkynsyreamider som cytostatiske og immunosuppresive midler
PT86536A (pt) Sistema terapeutico para ingredientes activos pouco soluveis
MY104050A (en) Preserving agents for wood and their application.
NZ331484A (en) Serine protease inhibitors having an alkynylamino side chain for use in treatment of thrombin related diseases
AR043071A1 (es) Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
DE69430385D1 (de) Hiv-proteaseinhibitoren
DE69705110T2 (de) Topische pharmazeutische zusammensetzungen, welche heparin enthalten
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
UY26514A1 (es) " composición para el tratamiento de tejidos danados".
GB9505082D0 (en) Medicament
MX9700036A (es) Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas.
IE840977L (en) Pharmaceutical preparations
BR0014751A (pt) Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto